A controlled, multicenter randomised phase 3 study of an extended release miconazole (50mg) bioadhesive buccal tablet once daily for local treatment of oropharyngeal candidiasis in head and neck cancer patients undergoing radiation therapy
Bensadoun, R.-J., Daoud, D., Bastit, L., El Gueddari, B., Allavena, C., Benidder, A., Gourmet, R., Ghabri, S., Chaumont, C., Dufour-Lamartinie, J.-F.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article